ScholarWorks@Hanyang University

Diabetes, Obesity and Metabolism

Journal Title

  • Diabetes, Obesity and Metabolism

ISSN

  • E 1463-1326 | P 1462-8902

Publisher

  • Blackwell Publishing Inc.

Listed on(Coverage)

JCR 2000-2019
SJR 2000-2019
CiteScore 2011-2019
SCIE 2010-2021
CC 2016-2021
SCOPUS 2017-2020
MEDLINE 2016-2021
EMBASE 2016-2020

Active

  • Active

    based on the information

    • SCOPUS:2020-10

Country

  • USA

Aime & Scopes

  • Developing World Bioethics provides long needed case studies, teaching materials, news in brief, and legal backgrounds to bioethics scholars and students in developing and developed countries alike. This companion journal to Bioethics also features high-quality peer reviewed original articles. It is edited by well-known bioethicists who are working in developing countries, yet it will also be open to contributions and commentary from developed countries' authors. Developing World Bioethics is the only journal in the field dedicated exclusively to developing countries' bioethics issues. The journal is an essential resource for all those concerned about bioethical issues in the developing world. Members of Ethics Committees in developing countries will highly value a special section dedicated to their work.

Homepage

Article List

1 - 17 out of 17 results.

SCIESCOPUS
Waist-to-Height Ratio and the Risk of Cardiovascular Outcomes and Mortality in Type 2 Diabetes With and Without Abdominal ObesityGo to Linkopen access

Park, Kye-Yeung; Han, Kyungdo; Park, Jung Hwan; Lee, Chang Beom; Park, Hoon-Ki; Hwang, Hwan-Sik; Hong, Sangmo; Yu, Sung Hoon

ArticleIssue Date2026CitationDIABETES OBESITY & METABOLISM, v.28, no.6, pp 4949 - 4960PublisherWILEY
SCIESCOPUS
Association of GLP-1 Receptor Agonists With Hepatic Decompensation in the All of Us Research ProgramGo to Linkopen access

Hwang, Inyoung; Kim, Yun; Lee, Sang Won

ArticleIssue Date2026CitationDIABETES OBESITY & METABOLISM, v.28, no.6, pp 4837 - 4846PublisherWILEY
SCIESCOPUS
Effectiveness and Safety of Evogliptin in Patients With Type 2 Diabetes Mellitus: A Multicenter, Prospective, Observational StudyGo to Linkopen access

Hong, Jun Hwa; Yu, Sung Hoon; Baek, Ki-hyun; Yu, Jaemyung; Lee, Seung Jin; Kim, Hyung-wook; Park, Kang Seo; Kim, Jung Han; Min, Kyungwan; Lee, Yong Hwan, et al.

ArticleIssue Date2026CitationDIABETES OBESITY & METABOLISM, v.28, no.5, pp 4112 - 4120PublisherWILEY
SCIESCOPUS
Efficacy and safety of adding a fourth oral antidiabetic drug versus metformin dose escalation in patients with type 2 diabetes inadequately controlled on triple oral combination therapy (EFFORT): A 24-week, randomized, open-label, multicenter trialGo to Link

Kim, So Ra; Hong, Jun Hwa; Kim, Sin Gon; Kim, Soo-Kyung; Kwon, Hyuk-Sang; Moon, Jun Sung; Park, Jung Hwan; Yu, Jae Myung; Cha, Bong-Soo; Lee, Byung-Wan

ArticleIssue Date2026CitationDIABETES OBESITY & METABOLISM, v.28, no.4, pp 3305 - 3316PublisherWILEY
SCIESCOPUS
Efficacy and safety of switching to ezetimibe 10 mg/rosuvastatin 2.5 mg in Korean patients with type 2 diabetes mellitus and dyslipidaemia: A multicentre, prospective study (EROICA study)Go to Linkopen access

Hong, Sangmo; Kim, Won J.; Kim, Sungrae; Park, Jung H.; Kang, Eun S.; Moon, Min K.; Kim, Jae T.; Mok, Ji-Oh; Lee, Ki Y.; Park, Cheol-Young, et al.

ArticleIssue Date2026CitationDIABETES OBESITY & METABOLISM, v.28, no.2, pp 906 - 913PublisherWILEY
SCIESCOPUS
Efficacy and safety of pioglitazone, empagliflozin and glimepiride as third-line agents in patients with type 2 diabetes inadequately controlled with metformin and DPP-4 inhibitors: A multicentre, phase 4 randomized controlled trialGo to Link

Cho, Yun Kyung; Cho, Jae-Hyoung; Hong, Sang-Mo; Park, Jung Hwan; Lee, Byung-Wan; Yoo, Jee Hee; Kim, Jae Hyeon; Chun, Sung Wan; Hwang, You-Cheol; Song, Kee-Ho, et al.

ArticleIssue Date2025CitationDiabetes, Obesity and Metabolism, v.27, no.11, pp 6375 - 6385PublisherBlackwell Publishing Inc.
SCIESCOPUS
Efficacy and safety of lobeglitazone added to metformin and sitagliptin combination therapy in patients with type 2 diabetes: A 52-week, multicentre, randomized, placebo-controlled, phase III clinical trialGo to Linkopen access

Hong, Eun-Gyoung; Min, Kyung-Wan; Chun, Sungwan; Chung, Choon Hee; Oh, Seungjoon; Lee, Chang Beom; Kim, Dong-Jun; Kim, Hye Soon; Mok, Ji Oh; Sohn, Tae Seo, et al.

ArticleIssue Date2025CitationDIABETES OBESITY & METABOLISM, v.27, no.10, pp 5727 - 5736PublisherWILEY
SCIESCOPUS
Efficacy and safety of a fixed-dose combination of dapagliflozin and linagliptin (AJU-A51) in patients with type 2 diabetes mellitus: A multicentre, randomized, double-blind, parallel-group, placebo-controlled phase III studyGo to Linkopen access

Hong, Jun Hwa; Kim, Myung Jin; Min, Kyung Wan; Won, Jong Chul; Kim, Tae Nyun; Lee, Byung-Wan; Kang, Jun Goo; Kim, Jae Hyeon; Park, Jung Hwan; Ku, Bon Jeong, et al.

ArticleIssue Date2025CitationDIABETES OBESITY & METABOLISM, v.27, no.1, pp 81 - 91PublisherWILEY
SCIESCOPUS
Fenofibrate and risk of end-stage renal disease: A nationwide cohort studyGo to Linkopen access

Hyun, Young Youl; Kim, Kyung-Soo; Hong, Sangmo; Han, Kyungdo; Park, Cheol-Young

ArticleIssue Date2024CitationDiabetes, Obesity and Metabolism, v.26, no.10, pp 4583 - 4590PublisherJohn Wiley and Sons Inc
SCIESCOPUS
A multicentre, double-blind, placebo-controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add-on therapy in type 2 diabetic patients treated with metformin and dapagliflozinGo to Link

Lim, Soo; Lee, Seung-Hwan; Min, Kyung-Wan; Lee, Chang Beom; Kim, Sang Yong; Yoo, Hye Jin; Kim, Nan Hee; Kim, Jae Hyeon; Oh, Seungjoon; Won, Jong Chul, et al.

ArticleIssue Date2024CitationDiabetes, Obesity and Metabolism, v.26, no.6, pp 2188 - 2198PublisherBlackwell Publishing Inc.
SCIESCOPUS
Cardiovascular safety of evogliptin in patients with type 2 diabetes: A nationwide cohort studyGo to Link

Park, So-Hee; Jeong, Han Eol; Oh, In-Sun; Hong, Sang-Mo; Yu, Sung Hoon; Lee, Chang Beom; Shin, Ju-Young

ArticleIssue Date2021CitationDIABETES OBESITY & METABOLISM, v.23, no.6, pp.1232 - 1241PublisherWILEY
SCIESCOPUS
Safety and effectiveness of linagliptin in Korean patients with type 2 diabetes: A postmarketing surveillance studyGo to Link

Bae, Jaehyun; Song, Kee-Ho; Park, Jong Suk; Lee, Jae Hyuk; Jeong, In-Kyung; Kim, Hyun Jin; Lim, Young-Hyo; Cho, Jae-Hyoung; Choi, Sung Hee; Chung, Yoon-Sok, et al.

ArticleIssue Date2021CitationDiabetes, Obesity and Metabolism, v.23, no.5, pp.1208 - 1212PublisherBlackwell Publishing Inc.
SCIESCOPUS
Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active-controlled, randomized, double-blind study with open-label extension (the EVERGREEN study)Go to Linkopen access

Kim, Gyuri; Lim, Soo; Kwon, Hyuk-Sang; Park, Ie B.; Ahn, Kyu J.; Park, Cheol-Young; Kwon, Su K.; Kim, Hye S.; Park, Seok W.; Kim, Sin G., et al.

ArticleIssue Date2020CitationDIABETES OBESITY & METABOLISM, v.22, no.9, pp.1527 - 1536PublisherWILEY
SCIESCOPUS
Efficacy and safety of ipragliflozin as an add-on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: A randomized controlled trialGo to Linkopen access

Han, Kyung-Ah; Chon, Suk; Chung, Choon Hee; Lim, Soo; Lee, Kwan-Woo; Baik, SeiHyun; Jung, Chang Hee; Kim, Dong-Sun; Park, Kyong Soo; Yoon, Kun-Ho, et al.

ArticleIssue Date2018CitationDIABETES OBESITY & METABOLISM, v.20, no.10, pp.2408 - 2415PublisherWILEY
SCIESCOPUS
Efficacy and safety of evogliptin monotherapy in patients with type 2 diabetes and moderately elevated glycated haemoglobin levels after diet and exerciseGo to Link

Park, Juri; Park, Sung Woo; Yoon, Kun Ho; Kim, Sung Rae; Ahn, Kyu Jeung; Lee, Jae Hyuk; Mok, Ji Oh; Chung, Choon Hee; Han, Kyung Ah; Koh, Gwan Pyo, et al.

ArticleIssue Date2017CitationDiabetes, Obesity and Metabolism, v.19, no.12, pp 1681 - 1687PublisherBlackwell Publishing Inc.
SCIESCOPUS
Efficacy and safety of adding evogliptin versus sitagliptin for metformin-treated patients with type 2 diabetes: A 24-week randomized, controlled trial with open label extensionGo to Link

Hong, Sang-Mo; Park, Cheol-Young; Hwang, Dong-Min; Han, Kyung Ah; Lee, Chang Beom; Chung, Choon Hee; Yoon, Kun-Ho; Mok, Ji-Oh; Park, Kyong Soo; Park, Sung-Woo

ArticleIssue Date2017CitationDiabetes, Obesity and Metabolism, v.19, no.5, pp 654 - 663PublisherBlackwell Publishing Inc.
SCIESCOPUS
Efficacy and safety of teneligliptin, a novel dipeptidyl peptidase-4 inhibitor, in Korean patients with type 2 diabetes mellitus: a 24-week multicentre, randomized, double-blind, placebo-controlled phase III trial

Hong, S.; Park, C. -Y.; Han, K. A.; Chung, C. H.; Ku, B. J.; Jang, H. C.; Ahn, C. W.; Lee, M. -K.; Moon, M. K.; Son, H. S., et al.

ArticleIssue Date2016CitationDiabetes, Obesity and Metabolism, v.18, no.5, pp 528 - 532PublisherBlackwell Publishing Inc.
1
CONTACT US

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366

COPYRIGHT © 2024 HANYANG UNIVERSITY.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어